Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114694) titled 'A multicenter, randomized, blinded (investigator-subject blind), parallel-group controlled clinical trial to evaluate the efficacy and safety of injectable Sodium Hyaluronate Composite Solution in improving skin dryness, dullness, and elasticity in adults' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Department of Dermatology, Beijing Friendship Hospital
Condition:
facial rejuvenation
Intervention:
Experimental group:Full-face injection of Sodium Hyaluronate Complex Solution produced by Zhu Yan Legend (Xiamen) Biotechnology Co., Ltd.
Recruitment Status: Not Re...